In our study, we found that the MYBL1 MYBL1 can increase Tregs, M2 macrophages, neutrophils, B cells, monocytes, CD8+ T cells, yet decrease endothelial cells level in the ccRCC microenvironment. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.